₹2013.1
+0.21% today
· 30d +4.31%
as of 2026-11-09
Price · Daily Candles
“Dr. Lal PathLabs' Net Profit Dips by 14.98% QoQ Amidst FII Sell-off and Q4 Revenue Growth.”
Dr. Lal PathLabs, valued at ₹26,783 Cr, faces a notable challenge as its quarterly net profit dropped by 14.98% YoY despite a 16.61% YoY revenue increase in Q4 2026. The stock trades at a TTM PE of 50.68, contrasting with its 3-year net profit CAGR of 28.75%, yet its Free Cash Flow (FCF) growth predictions are弱.
BULL CASE
+Q4 2026 revenue increased by 16.61% YoY to ₹703 Cr, demonstrating consistent top-line growth.
+Annual revenue for FY26 grew by 12.25% to ₹2,763 Cr, with a strong 3-year net profit CAGR of 28.75%.
+Promoters maintain a significant stake of 53.21% as of March 2026, indicating confidence.
+The company demonstrated a 1:1 bonus share issue on December 19, 2025, reflecting returns to shareholders.
BEAR CASE
−Net profit in Q4 2026 decreased by 14.98% YoY to ₹132 Cr, despite revenue growth.
−Operating Profit Margin (OPM) declined by 1.99% YoY in Q4 2026.
−Foreign Institutional Investors (FIIs) reduced their stake by 3.11% QoQ, bringing it to 17.18% in March 2026.
−The stock is trading at a high TTM PE of 50.68 and a PB of 11.21, significantly above its historical averages.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹874 Cr
+19.61% YoY
NET PROFIT
₹194 Cr
+27.4% YoY
OPM
34.63%
+1.68pp YoY
EPS
₹11.51
PE 50.68
Intrinsic value · DCF ₹370.27 · Margin of safety -81.6% (overvalued) · FCF yield 1.39%
◇ Sector Position
Dr. Lal PathLabs' TTM PE of 50.68 is lower than Vijaya Diagnostic Centre (74.93) but higher than Thyrocare's 49.03, while its ROCE of 28.0% is competitive against Sailife (18.42%) and Metropolis (20.67%).
PEERPEROCE %
LALPATHLAB50.6828.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
67
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
90
Valuation
STRETCHED
20
Growth
STEADY
63
Profitability
HIGH
92
Technicals
NEUTRAL
58
Risk
LOW
80
Key Stats
TTM PE
50.68
P/B
11.21
52W HIGH
₹2079.0
OFF HIGH
-3.17%
DIV YIELD
0.87%
MKT CAP
₹33736 Cr
◉ Active Signals
MACDBullish15.0289
RSI(14)Bullish61.51
Near 52W HighBullish-3.17
Street Consensus
26 analysts₹1686.0
mean target
Low ₹1180.0Now ₹2013.1High ₹2072.0
⧉ Strategy Fit 🔒